NuProbe USA Inc, Houston, TX, USA.
Department of Bioengineering, Rice University, Houston, TX, USA.
Genome Biol. 2021 Sep 6;22(1):227. doi: 10.1186/s13059-021-02449-1.
We develop the Oncogene Concatenated Enriched Amplicon Nanopore Sequencing (OCEANS) method, in which variants with low variant allele frequency (VAFs) are amplified and subsequently concatenated for Nanopore Sequencing. OCEANS allows accurate detection of somatic mutations with VAF limits of detection between 0.05 and 1%. We construct 4 distinct multi-gene OCEANS panels targeting recurrent mutations in acute myeloid leukemia, melanoma, non-small- cell lung cancer, and hepatocellular carcinoma and validate them on clinical samples. By demonstrating detection of low VAF single nucleotide variant mutations using Nanopore Sequencing, OCEANS is poised to enable same-day clinical sequencing panels.
我们开发了 Oncogene Concatenated Enriched Amplicon Nanopore Sequencing(OCEANS)方法,该方法对低变异等位基因频率(VAF)的变体进行扩增,然后连接起来进行 Nanopore 测序。OCEANS 允许对 VAF 检测限在 0.05%至 1%之间的体细胞突变进行准确检测。我们构建了 4 个不同的针对急性髓系白血病、黑色素瘤、非小细胞肺癌和肝细胞癌中常见突变的多基因 OCEANS 检测 panel,并在临床样本上对其进行了验证。通过证明使用 Nanopore Sequencing 检测低 VAF 的单核苷酸变异突变,OCEANS 有望实现当天的临床测序 panel。